triamcinolone acetonide has been researched along with Angiogenesis, Pathologic in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakar, B; Budak Yildiran, FA; Dincel, GC; Sari, E | 1 |
| Jonas, JB; Libondi, T; Schlichtenbrede, F; Schmidbauer, M | 1 |
| Andrade, SP; Ayres, E; Da Silva, GR; Da Silva-Cunha Junior, A; Lima, LD; Moura, SA; Oréfice, RL; Pinto, FC | 1 |
| Jonas, JB; Söfker, A | 1 |
| Lang, GE | 1 |
| Degenring, RF; Jonas, JB; Kreissig, I | 2 |
| Danis, RP; Harris, A; Pratt, LM; Rechtman, E | 1 |
| Entezari, M; Kadkhodaei, S; Moradian, S; Ramezani, A; Tabatabaei, H | 1 |
| Inoue, Y; Iriyama, A; Obata, R; Takahashi, H; Tamaki, Y; Yanagi, Y | 1 |
| Chen, FK; Chen, SD; Patel, C | 1 |
| Arnaud, C; Audrey, L; Fournie, P; Leparmentier, A; Mathis, A; Quintyn, JC | 1 |
| Bienias, W; Nowak, JZ | 1 |
| Ehrenberg, M; Machemer, R; McCuen, BW; Schindler, RH | 1 |
| Hayler, JK; Jonas, JB; Panda-Jonas, S; Söfker, A | 1 |
| Goerz, G; Jansen, T; Megahed, M; Plewig, G; Rübo, J; Schotte, U; Vandieken, R | 1 |
| Landers, MB; Morse, LS; Semple, HC | 1 |
| Chandler, DB; de Juan, E; Machemer, R; Rozakis, G | 1 |
| Ishibashi, T; Miki, K; Patterson, R; Ryan, SJ; Sorgente, N | 1 |
1 review(s) available for triamcinolone acetonide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Bevacizumab; Humans; Lipofuscin; Macular Degeneration; Neovascularization, Pathologic; Photochemotherapy; Pregnadienediols; Ranibizumab; Retinal Drusen; Triamcinolone Acetonide | 2007 |
2 trial(s) available for triamcinolone acetonide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris; Male; Middle Aged; Neovascularization, Pathologic; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone.
Topics: Aged; Aged, 80 and over; Crystallization; Diabetic Retinopathy; Female; Glaucoma, Neovascular; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris; Male; Middle Aged; Neovascularization, Pathologic; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2001 |
16 other study(ies) available for triamcinolone acetonide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Effects of DMSO on a rabbit ear hypertrophic scar model: A controlled randomized experimental study.
Topics: Animals; Anti-Inflammatory Agents; Cicatrix, Hypertrophic; Collagen Type I; Collagen Type III; Dimethyl Sulfoxide; Disease Models, Animal; Ear; Free Radical Scavengers; Gene Expression; Injections, Intralesional; Interferon-gamma; Male; Neovascularization, Pathologic; Rabbits; Random Allocation; RNA, Messenger; Transforming Growth Factor beta1; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha | 2017 |
Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Fluorescein Angiography; Glaucoma, Angle-Closure; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris; Neovascularization, Pathologic; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Controlled release of triamcinolone acetonide from polyurethane implantable devices: application for inhibition of inflammatory-angiogenesis.
Topics: Animals; Anti-Inflammatory Agents; Biocompatible Materials; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Female; Inflammation; Materials Testing; Mice; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Polyurethanes; Scattering, Small Angle; Spectroscopy, Fourier Transform Infrared; Triamcinolone Acetonide; X-Ray Diffraction | 2012 |
Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization.
Topics: Aged; Cataract; Cataract Extraction; Female; Glucocorticoids; Humans; Injections; Iris; Lenses, Intraocular; Neovascularization, Pathologic; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2002 |
[Steroid therapy of oedematous and neovascular eye diseases].
Topics: Anti-Inflammatory Agents; Glucocorticoids; Humans; Injections; Iris; Macular Edema; Neovascularization, Pathologic; Retinal Neovascularization; Triamcinolone Acetonide; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy.
Topics: Aged; Anti-Inflammatory Agents; Eye; Humans; Injections; Intraocular Pressure; Iris; Ischemia; Male; Neovascularization, Pathologic; Ocular Hypotension; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body; Vitreous Hemorrhage; Waldenstrom Macroglobulinemia | 2003 |
Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroid; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Neovascularization, Pathologic; Photochemotherapy; Retrospective Studies; Triamcinolone Acetonide | 2004 |
Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Macula Lutea; Macular Degeneration; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Retinal Detachment; Triamcinolone Acetonide; Visual Acuity | 2004 |
Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro.
Topics: Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Eye Proteins; Glucocorticoids; Humans; Neovascularization, Pathologic; Nerve Growth Factors; Photochemotherapy; Photosensitizing Agents; Pigment Epithelium of Eye; Porphyrins; Protease Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serpins; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin | 2007 |
Opaque coating of an intraocular lens and regression of iris neovascularization following injection of triamcinolone acetonide into the anterior chamber.
Topics: Anterior Chamber; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Iris; Laser Coagulation; Lenses, Intraocular; Middle Aged; Neovascularization, Pathologic; Pseudophakia; Triamcinolone Acetonide; Vitrectomy; Vitreous Hemorrhage | 2006 |
[Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroid; Combined Modality Therapy; Female; Humans; Macular Degeneration; Male; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Detachment; Retrospective Studies; Triamcinolone Acetonide; Verteporfin | 2007 |
Rubeosis iridis: preoperative iris fluorescein angiography and periocular steroids.
Topics: Diabetic Retinopathy; Drug Therapy, Combination; Fluorescein Angiography; Glaucoma; Humans; Iris; Neovascularization, Pathologic; Ophthalmic Solutions; Postoperative Care; Postoperative Complications; Prednisolone; Triamcinolone Acetonide; Vitreous Body | 1984 |
[Angioimmunoblastic lymphadenopathy with cutaneous manifestations in a 13-year-old girl].
Topics: Administration, Topical; Adolescent; Biopsy; Female; Gentamicins; HLA-DR Antigens; Humans; Immunoblastic Lymphadenopathy; Neovascularization, Pathologic; Skin; T-Lymphocytes; Triamcinolone Acetonide | 1992 |
Optic disk neovascularization in juvenile rheumatoid arthritis.
Topics: Arthritis, Juvenile; Cataract; Cataract Extraction; Child, Preschool; Female; Fluorescein Angiography; Fundus Oculi; Humans; Neovascularization, Pathologic; Optic Disk; Triamcinolone Acetonide; Visual Acuity | 1990 |
The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Disease Models, Animal; Eye Diseases; Neovascularization, Pathologic; Rabbits; Retinal Detachment; Retinal Diseases; Retinal Perforations; Time Factors; Triamcinolone Acetonide; Vitreous Body | 1985 |
Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate.
Topics: Animals; Dexamethasone; Laser Therapy; Lasers; Macaca fascicularis; Neovascularization, Pathologic; Prostheses and Implants; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1985 |